Breadcrumb Home News Twin Cities patients must travel for monoclonal antibodies COVID-19 treatment Twin Cities patients must travel for monoclonal antibodies COVID-19 treatment September 29, 2021 JP Leider, PhD comments on privilege and fairness regarding access to the increasingly in-demand treatment. Previous News Five Years After COVID-19 Lockdown, Racial Health Disparities Linger 2025 Societal Impact Award 5 Years Later: How COVID-19 Changed Minnesotans
